We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$998M
AUM Growth
+$120M
Cap. Flow
+$37.6M
Cap. Flow %
3.76%
Top 10 Hldgs %
30.51%
Holding
114
New
5
Increased
36
Reduced
8
Closed
5

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$11M
2
F icon
Ford
F
+$8.24M
3
MMP
Magellan Midstream Partners, L.P.
MMP
+$7.18M
4
EQR icon
Equity Residential
EQR
+$6.22M
5
EPD icon
Enterprise Products Partners
EPD
+$5.17M

Top Sells

Rank Stock Value
1
GIS icon
General Mills
GIS
+$9.38M
2
CAT icon
Caterpillar
CAT
+$8.76M
3
PRU icon
Prudential Financial
PRU
+$8.66M
4
MET icon
MetLife
MET
+$7.74M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.39M

Sector Composition

Rank Sector Weight
1 Consumer Staples 14.07%
2 Technology 13.88%
3 Financials 10.31%
4 Industrials 8.21%
5 Communication Services 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
76
Thermo Fisher Scientific
TMO
$211B
$111K 0.01%
700
– –
ECL icon
77
Ecolab
ECL
$75.6B
$110K 0.01%
900
– –
AMGN icon
78
Amgen
AMGN
$203B
$108K 0.01%
650
– –
NKE icon
79
Nike
NKE
$61.9B
$105K 0.01%
2,000
– –
IWF icon
80
iShares Russell 1000 Growth ETF
IWF
$122B
$104K 0.01%
4,000
– –
SRCL
81
DELISTED
Stericycle Inc
SRCL
$96K 0.01%
1,200
– –
ETP
82
DELISTED
Energy Transfer Partners L.p.
ETP
$92K 0.01%
2,473
– –
MIN
83
Aberdeen Intermediate Income Fund
MIN
$273M
$91K 0.01%
20,000
– –
SCHW
84
Charles Schwab
SCHW
$177B
$83K 0.01%
2,633
– –
MCR
85
DELISTED
MFS Charter Income Trust
MCR
$81K 0.01%
9,400
– –
GOOGL icon
86
Alphabet (Google) Class A
GOOGL
$3.91T
$80K 0.01%
2,000
– –
GOOG icon
87
Alphabet (Google) Class C
GOOG
$3.9T
$78K 0.01%
2,000
– –
BRK.B icon
88
Berkshire Hathaway Class B
BRK.B
$1.07T
$72K 0.01%
496
– –
NVS icon
89
Novartis
NVS
$295B
$69K 0.01%
978
– –
MGF
90
Aberdeen Government Markets Income Fund
MGF
$91.6M
$67K 0.01%
12,433
– –
PPT
91
Franklin Premier Income Trust
PPT
$323M
$66K 0.01%
13,464
– –
PIM
92
Franklin Master Intermediate Income Trust
PIM
$149M
$61K 0.01%
13,690
– –
ORCL icon
93
Oracle
ORCL
$331B
$59K 0.01%
1,500
– –
ITW icon
94
Illinois Tool Works
ITW
$81.4B
$48K ﹤0.01%
400
– –
DHR icon
95
Danaher
DHR
$135B
$47K ﹤0.01%
677
-216
-24% -$15.3K
CSX icon
96
CSX Corp
CSX
$98.6B
$46K ﹤0.01%
4,500
– –
LLL
97
DELISTED
L3 Technologies, Inc.
LLL
$45K ﹤0.01%
300
– –
CL icon
98
Colgate-Palmolive
CL
$72.6B
$44K ﹤0.01%
600
– –
MPLX icon
99
MPLX
MPLX
$59.5B
$44K ﹤0.01%
1,308
– –
DE icon
100
Deere & Co
DE
$170B
$43K ﹤0.01%
500
– –
1 2 3
4
5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2016 Portfolio in Review

As of Q3 2016, Payden & Rygel held 114 positions worth $998M, up 14% from $878M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Payden & Rygel deployed $37.6M of net new capital in Q3 2016, opening 5 new positions and adding to 36 existing holdings. Its largest new stake was Teva Pharmaceuticals: 211,600 shares worth $9.74M.

By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was General Mills, an estimated $9.38M trimmed.

  • Payden & Rygel's largest Q3 2016 buy was Teva Pharmaceuticals: 211,600 shares worth $9.74M.
  • Payden & Rygel added most to Magellan Midstream Partners, L.P. in Q3 2016, an estimated $7.18M increase.
  • Payden & Rygel's biggest Q3 2016 reduction was General Mills, cutting an estimated $9.38M.
  • Payden & Rygel fully exited Caterpillar in Q3 2016, selling an estimated $8.76M.
  • Payden & Rygel's ten largest holdings make up 31% of its $998M portfolio in Q3 2016.
  • Payden & Rygel opened 5 new positions and closed 5 in Q3 2016.
  • Payden & Rygel's portfolio value rose 14% quarter-over-quarter to $998M.

Based on Payden & Rygel's 13F filing for Q3 2016, filed 9 Nov 2016.